64028-90-6

Basic information

• Product Name: (S)-1,4-DIBROMO-2-BUTANOL
• Synonyms: 2-BUTANOL, 1,4-DIBROMO-, (S);(S)-1,4-DIBROMO-2-BUTANOL;(S)-1,4-Dibromo-2-butanol,96%;(S)-1,4-Dibromobutan-2-ol
• CAS NO: 64028-90-6
• Molecular Formula: C₄H₈Br₂O
• Molecular Weight: 231.91
• Mol File: 64028-90-6.mol
• Article Data: 5

Chemical Properties

• Melting Point: 33-36 °C
• Boiling Point: 114-115 °C (13 mmHg)
• Flash Point: 116.5 °C
• Appearance: clear light brown liquid
• Density: 2.001
• Refractive Index: 1.536-1.54
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (S)-1,4-DIBROMO-2-BUTANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1,4-DIBROMO-2-BUTANOL(64028-90-6)
• EPA Substance Registry System: (S)-1,4-DIBROMO-2-BUTANOL(64028-90-6)

Safety Data

• Safety Statements: 24/25
• WGK Germany: 3
• Hazardous Substances Data: 64028-90-6(Hazardous Substances Data)

Upstream product

• 70005-88-8 (R)-1,2,4-butanetriol 
• 26562-23-2 (Ξ)-2-((S)-3-bromo-1-bromomethyl-propoxy)-tetrahydro-pyran 
• 76494-96-7 (2S,1'RS)-2-(1'-ethoxyethyloxy)-1,4-butanediyl bis(p-toluenesulfonate) 
• 42890-76-6 (S)-1,2,4-butanetriol 

Downstream Products

• 79413-93-7 (R)-4-bromo-1,2-butylene epoxide 
• 1147732-43-1 (S)-tert-butyl((1,4-dibromobutan-2-yl)oxy)diphenylsilane 
• 748810-28-8 Vernakalant hydrochloride 
• 794466-70-9 (3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidin-3-ol 

Relevant articles and documents

HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF

Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of their use. The condition or disorder mediated by HDAC comprises a neurodegenerative pathology. Accordingly, also provided is a method of treating a neurodegenerative pathology mediated by HDAC in a subject in need of such a treatment, comprising administering to the subject a therapeutically effective amount of at least one compound, or pharmaceutically acceptable salt thereof, described herein.

HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS

Provided are certain histone deacetylase (HDAC) inhibitors of Formula (I), compositions thereof, and methods of their use.

Synthesis of optically active 2-methyl- and 2-ethyl-1,6-dioxaspiro[4.4]nonane- and -[4.5]decane pheromones from a common chiral precursor

-